“Everyone poops,” declares the classic children’s book used by parents, including me, to help their kids understand what is a natural part of all animals’ lives. “Everyone poops — and… Read More
The University of Washington’s Institute for Protein Design is on a hot streak. New studies, companies and spinouts are emerging at a rapid clip from the research hub, propelled by… Read More
The culture of collaboration in the Pacific Northwest, the impact of AI on biopharma, and the shape of new business models driven by AI were all topics at a panel… Read More
Travis Rush grew up in the tiny seaside town of Gold Beach in Southern Oregon. With a population of only 1,576 — as was proudly proclaimed on the sign coming… Read More
Boston-based biotech company Vertex Pharmaceuticals agreed to acquire Seattle-based Alpine Immune Sciences for $65 per share, totaling about $4.9 billion in cash, a 38% premium over Alpine’s closing price on… Read More
A new test for the early detection of Alzheimer’s Disease — potentially even before symptoms are present — show that the diagnostic caught the neurodegenerative disease in 100% of the… Read More
ProfoundBio, a Seattle-based biotech firm developing drugs to treat ovarian and endometrial cancers, will be acquired by publicly traded Danish drugmaker Genmab in a $1.8 billion all-cash deal expected to… Read More
The news: Modulus Therapeutics, a Seattle-based cellular therapy company spun out of the Allen Institute of Artificial Intelligence (AI2) Incubator, has sold its cell therapy platform assets to the Boston… Read More
Researchers opened the doors Monday to the new Seattle Hub for Synthetic Biology, a collaboration between the Allen Institute, the Chan Zuckerberg Initiative and the University of Washington. The hub combines “academic creativity with… Read More
Sonoma Biotherapeutics on Monday hosted a ribbon cutting ceremony at its new research and development center and office space on Seattle’s waterfront. The biotech company, which has a second location… Read More
A good idea, preliminary data, and credentials in the field are all key components of landing a small business grant from the U.S. government to launch or expand a company.… Read More
More than 100 researchers — including a Nobel laureate — have signed on to a call for the scientific community to follow a set of safety and security standards when… Read More
Seattle biotech startup Phase Genomics is receiving $1.5 million from the Bill & Melinda Gates Foundation to fund research into two important areas: killing drug-resistant bacteria and battling methane-producing microorganisms… Read More
The Institute for Protein Design at the University of Washington is a startup factory, spinning out companies developing new protein-based therapeutics, industrial enzymes, materials, biosensors and more. A key to… Read More
A team working on prolonging the lifespan of transplant organs took home the top prize in the 9th annual Hollomon Health Innovation Challenge at the University of Washington. BioLegacy, made up of… Read More
PATH, the global health nonprofit, is moving to a new headquarters space in Seattle’s Fremont neighborhood after 15 years in South Lake Union. PATH announced a lease agreement Thursday with… Read More
Healionics, a Seattle-based medical technology company, raised $5.5 million in new financing aimed at helping the company complete an ongoing human trial and pursue regulatory clearance and commercialization of its… Read More
Biotech giant AstraZeneca has completed its $1.1 billion acquisition of Icosavax, a Seattle-based spinout from the University of Washington’s Institute for Protein Design.
ProfoundBio raised $112 million to support development of its pipeline of antibody-drug conjugates (ADCs), agents that recognize a molecular target via an antibody and deliver a toxin or other compound to… Read More
Just in time for new year’s resolutions, the Fred Hutchinson Cancer Center is releasing a free app that employs an artificial intelligence-powered chatbot to help people stop smoking. Through an… Read More
The halls at a recent meeting of biologists in Seattle were buzzing with more than just the usual excitement about spiders, bats, bees, elephants and other creatures. Researchers were also… Read More
A new Seattle-based startup called Avante confirmed that it raised $10 million in a seed funding round led by Fuse Venture Partners, saying it’s building a company with ambitions to… Read More
Yuzi founder Stephiney Foley graduated from West Point and worked for the U.S. Army for more than seven years, serving as a platoon leader in Afghanistan and Hawaii and a… Read More
Editor’s note: William Canestaro is managing director at Seattle venture capital firm WRF Capital and leads the biotechnology investment team. Seagen’s sale to Pfizer would have seemed unthinkable a few… Read More
Prenuvo, the celebrity-endorsed company offering $2,500 full-body MRI scans designed to detect cancer and other diseases early, is planning to open one of its clinics in Seattle in 2024. Silicon… Read More
Neuroscientists have unveiled their most comprehensive and detailed map of cell types across the entire mouse brain, delivering the latest results of a six-year-long scientific effort in which Seattle’s Allen… Read More
Pfizer’s plan to acquire Seagen for $43 billion has cleared the necessary regulatory hurdles, the pharma titan announced Tuesday. The deal will close on Thursday. Seagen is the largest biotech… Read More
Seattle-based Icosavax, a spin-out from the University of Washington’s Institute for Protein Design, will be acquired by biotech giant AstraZeneca for up to $1.1 billion. The pending acquisition, announced Tuesday, values… Read More
The Allen Institute, the Chan Zuckerberg Initiative and the University of Washington have launched a collaboration called the Seattle Hub for Synthetic Biology, with the goal of using genetically modified… Read More
Valant Medical Solutions, a Seattle startup that develops software to help behavioral health practitioners manage billing and electronic medical records at their offices, has been sold to Resurgens Technology Partners, a private… Read More